摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

反式-4-环己基-L-脯氨酸 | 103201-78-1

中文名称
反式-4-环己基-L-脯氨酸
中文别名
反-4-环己基-L-脯氨酸;福辛普利中间体;福辛普利中间体-2
英文名称
(2S,4S)-4-cyclohexylpyrrolidine-2-carboxylic acid
英文别名
trans-4-cyclohexylproline;(2S,4S)-4-cyclohexylpyrrolidin-1-ium-2-carboxylate
反式-4-环己基-L-脯氨酸化学式
CAS
103201-78-1
化学式
C11H19NO2
mdl
MFCD08061929
分子量
197.277
InChiKey
XRZWVSXEDRYQGC-ZJUUUORDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    260-262 °C(Solv: methanol (67-56-1); ethyl ether (60-29-7))
  • 沸点:
    343.9±35.0 °C(Predicted)
  • 密度:
    1.113±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.909
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P280
  • 危险性描述:
    H302,H317

SDS

SDS:2f03b945ca5d9e077a578218ebb02b9c
查看

制备方法与用途

制备方法

福辛普利钠中间体的制备方法未详细说明。

用途简介

具体用途尚未提及。

反应信息

  • 作为反应物:
    描述:
    反式-4-环己基-L-脯氨酸盐酸N,N-二异丙基乙胺 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺 为溶剂, 反应 18.5h, 生成
    参考文献:
    名称:
    Design and structure–activity relationships of novel inhibitors of human rhinovirus 3C protease
    摘要:
    Human rhinovirus (HRV) is a primary cause of common cold and is linked to exacerbation of underlying respiratory diseases such as asthma and COPD. HRV 3C protease, which is responsible for cleavage of viral polyprotein in to proteins essential for viral life-cycle, represents an important target. We have designed proline- and azetidine-based analogues of Rupintrivir that target the P2 pocket of the binding site. Potency optimization, aided with X-ray crystallography and quantum mechanical calculations, led to compounds with activity against a broad spectrum of HRV serotypes. Altogether, these compounds represent alternative starting points to identify promising leads in our continual efforts to treat HRV infections. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2016.05.066
  • 作为产物:
    描述:
    N-benzyl-L-pyroglutamic acid 在 palladium on activated charcoal 劳森试剂正丁基锂氢气三乙胺六甲基二硅氮烷 作用下, 以 四氢呋喃乙醇乙酸乙酯甲苯 为溶剂, -10.0~100.0 ℃ 、2.03 MPa 条件下, 反应 21.5h, 生成 反式-4-环己基-L-脯氨酸
    参考文献:
    名称:
    A convenient method for synthesis of trans-4-cyclohexyl-l-proline
    摘要:
    A convenient rnethod for the synthesis of the fosinopril precursor, trans-4-cyclohexyl-L-proline 1. has been developed. A highly stereoselective alkylation of N-benzyl-pyroglutamic acid 2 with 3-bromocyclohexene at -10degreesC and subsequent hydrogenolysis afforded the trans-4-cyclohexyl-L-pyroglutamic acid 4. The esterified 4 was sulfurized with Lawesson's reagent, desulfurized with Raney-Ni and hydrogenolytic cleavage of the benzyl protecting groups to afford 1 with 93% e.e. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0957-4166(02)00052-6
点击查看最新优质反应信息

文献信息

  • 一种降压药福辛普利钠及其关键中间体的制 备方法
    申请人:常州制药厂有限公司
    公开号:CN107365268B
    公开(公告)日:2021-02-05
    本发明涉及适用于工业化生产的一种降压药福辛普利钠及其关键中间体反式‑4‑苯基‑L‑脯氨酸的制备方法,其中关键中间体反式‑4‑苯基‑L‑脯氨酸的合成手性选择性高,方法简便易操作。
  • TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY
    申请人:Jung Francoise
    公开号:US20120283168A1
    公开(公告)日:2012-11-08
    Novel template-fixed β-hairpin peptidomimetics of the general formula (I) wherein the single elements T or P are α-amino acid residues connected in either direction which, depending on their positions in the chain, are as defined in the description and the claims, and salts thereof, have the property to antagonize the receptor CCR10. They can be used as medicaments to treat or prevent diseases or conditions in the area of dermatological and cutaneous disorders, inflammation, allergic disorders, respiratory diseases, diseases of the gastro-intestinal tract, ophthalmic diseases, haematology and cancer. These β-hairpin peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    具有以下一般式(I)的小说模板固定β-发夹仿生肽,其中单个元素T或P是α-氨基酸残基,可以连接在任何方向上,具体取决于它们在链中的位置,如描述和索赔中所定义,及其盐,具有拮抗受体CCR10的特性。它们可用作药物,用于治疗或预防皮肤病和皮肤疾病、炎症、过敏性疾病、呼吸道疾病、胃肠道疾病、眼科疾病、血液学和癌症等领域。这些β-发夹仿生肽可以通过基于混合固相和溶液相合成策略的过程制备。
  • TEMPLATE-FIXED PEPTIDOMIMETICS WITH CXCR7 MODULATING ACTIVITY
    申请人:Gombert Frank Otto
    公开号:US20130225506A1
    公开(公告)日:2013-08-29
    Novel template-fixed β-hairpin peptidomimetics of the general formula (I), wherein the single elements T or P are α-amino acid residues connected from the carbonyl (C═O) point of attachment to the nitrogen (N) of the next element in clockwise direction and wherein said elements, depending on their positions in the chain, are defined in the description and the claims have the property to act on the receptor CXCR7. Thus, these β-hairpin peptidomimetics can be useful in the treatment or prevention of diseases or conditions in the area of dermatological disorders, metabolic diseases, inflammatory diseases, fibrotic diseases, infectious diseases, neurological diseases, cardiovascular diseases, respiratory diseases, gastro-intestinal tract disorders, urological diseases, ophthalmic diseases, stomatological diseases, haematological diseases and cancer; or the mobilisation of stem cells.
    该模板固定的β-折叠肽类似物具有一般式(I),其中单个元素T或P是α-氨基酸残基,从羰基(C═O)连接点连接到顺时针方向下一个元素的氮(N),并且这些元素根据它们在链中的位置在说明书和权利要求中定义,具有作用于CXCR7受体的特性。因此,这些β-折叠肽类似物可用于治疗或预防皮肤疾病、代谢性疾病、炎症性疾病、纤维性疾病、感染性疾病、神经系统疾病、心血管疾病、呼吸系统疾病、胃肠道疾病、泌尿系统疾病、眼科疾病、口腔疾病、血液学疾病和癌症;或干细胞的动员。
  • Process for the preparation of fosinopril and intermediates thereof
    申请人:Dipharma Francis S.r.l.
    公开号:EP2264039A1
    公开(公告)日:2010-12-22
    Process for the preparation of intermediates useful in the synthesis of [1[S(R)],2α,4β]-4-cyclohexyl-1-[[[(2-methyl-1-oxypropoxy) propoxy](4-phenylbutyl) phosphinyl]acetyl]-L-proline, and the synthesis thereof, in particular as sodium salt.
    制备中间体的过程,该中间体在合成[1[S(R)],2α,4β]-4-环己基-1-[[[(2-甲基-1-氧丙氧基)丙氧基](4-苯基丁基)膦酰基]乙酰基]-L-脯氨酸时有用,特别是其钠盐的合成过程。
  • PROCESS FOR THE SYNTHESIS OF FOSINOPRIL AND INTERMEDIATES THEREOF
    申请人:RAZZETTI Gabriele
    公开号:US20100297711A1
    公开(公告)日:2010-11-25
    Process for the preparation of intermediates useful in the synthesis of [1[S(R)],2α,4β]-4-cyclohexyl-1-[[[(2-methyl-1-oxypropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline, and the synthesis thereof, in particular as sodium salt.
    制备中间体的过程,该中间体在合成[1[S(R)],2α,4β]-4-环己基-1-[[[(2-甲基-1-氧丙氧基)丙氧基](4-苯基丁基)膦酰基]乙酰基]-L-脯氨酸,尤其是其钠盐的合成中有用。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物